http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7320979-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cf7f3f36d20185ce15a2d1f04d5fdc1 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-72 |
filingDate | 2004-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2008-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6de7bccf70f9069e09abb39663bdaad8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdfe2b06593eb1a6798de51d05b15947 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a79148a95ad1d4777b62be9e7274284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1637b9342e98b40bcc10c5a541a51c10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29c841e23487588f6b669c337958bb6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d99321f6e905f02e7614209bb8f9f04b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4edc8e6d60e76f8d35fb0a0248124831 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1238af740b86060263c67e41ae86b4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac33301e5c8c5d28d40d0c3e77ad59cb |
publicationDate | 2008-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-7320979-B2 |
titleOfInvention | N-[(piperazinyl)hetaryl]arylsulfonamide compounds |
abstract | The invention relates to N-[(piperazinyl)hetaryl]arylsulfonamide compounds of the general formula I n nin whichn Q is a bivalent, 6-membered heteroaromatic radical which possesses 1 or 2 N atoms as ring members and which optionally carries one or two substituents R a which is/are selected, independently of each other, from halogen, CN, NO 2 , CO 2 R 4 , COR 5 , C 1 -C 4 -alkyl and C 1 -C 4 -haloalkyl; Ar is phenyl or a 6-membered heteroaromatic radical which possesses 1 or 2 N atoms as ring members and which optionally carries one or two substituents R b , which is/are selected from halogen, NO 2 , CN, CO 2 R 4 , COR 5 , C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl and C 1 -C 4 -haloalkyl, with it also being possible for two radicals R b which are bonded to adjacent C atoms of Ar to be together C 3 -C 4 -alkylene; R 1 is hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl, C 1 -C 4 -hydroxyalkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 3 -C 4 -alkenyl or C 3 -C 4 -alkynyl;n nwith the radicals n, R 1 , R 2 , R 3 , R 4 and R 5 having the meanings given in the patent claims, to the N-oxides and to the physiologically tolerated acid addition salts of these compounds and to pharmaceutical compositions which comprise at least one N-[(piperazinyl)hetaryl]arylsulfonamide compound as claimed in one of claims 1 to 10 and/or at least one physiologically tolerated acid addition salt of I and/or an N-oxide of I, where appropriate together with physiologically acceptable carriers and/or auxiliary substances for treating diseases which respond to influencing by dopamine D 3 receptor antagonists or agonists, in particular for treating diseases of the central nervous system and disturbances of kidney function. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8497273-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8476275-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007275952-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007054918-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010210664-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010048582-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8013156-B2 |
priorityDate | 2003-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 992.